# Survival in Myelofibrosis Patients After Allogeneic Hematopoietic Stem Cell Transplantation in Five Centers in France

> **NCT04282421** · — · COMPLETED · sponsor: **Central Hospital, Nancy, France** · enrollment: 58 (actual)

## Conditions studied

- Myelofibrosis

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04282421
- **Lead sponsor:** Central Hospital, Nancy, France
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2007-01-01
- **Primary completion:** 2017-12-31
- **Final completion:** 2020-02-01
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2020-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04282421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04282421, "Survival in Myelofibrosis Patients After Allogeneic Hematopoietic Stem Cell Transplantation in Five Centers in France". Retrieved via AI Analytics 2026-08-01 from https://api.ai-analytics.org/clinical/NCT04282421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*